• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化脓性汗腺炎作为一种自身炎症性皮肤病的证据。

Evidence on Hidradenitis Suppurativa as an Autoinflammatory Skin Disease.

作者信息

D'Onghia Martina, Malvaso Dalma, Galluccio Giulia, Antonelli Flaminia, Coscarella Giulia, Rubegni Pietro, Peris Ketty, Calabrese Laura

机构信息

Dermatology Unit, Department of Medical, Surgical and Neurological Sciences, University of Siena, 53100 Siena, Italy.

UOC di Dermatologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario A. Gemelli - IRCCS, 00168 Rome, Italy.

出版信息

J Clin Med. 2024 Sep 2;13(17):5211. doi: 10.3390/jcm13175211.

DOI:10.3390/jcm13175211
PMID:39274425
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11396593/
Abstract

Hidradenitis suppurativa (HS) is a chronic and debilitating inflammatory skin disease that often exhibits heterogeneity in its clinical presentation, especially in the context of its rare syndromic forms. The pathogenesis of HS results from a complex interplay of genetic predisposition, innate and adaptive immunity dysregulation, smoking, obesity and environmental factors. In the early phase of the disease, the innate immune system is hyperactivated, contributing to tissue damage and triggering the activation and amplification of the adaptive immune response, which plays a pivotal role in the chronic stages of the disease. Recent studies focused on elucidating the importance of innate immunity impairment and autoinflammation in HS and increasing evidence has emerged on the occurrence of the disease in the context of well-known monogenic and polygenic autoinflammatory syndromes (AIDs). This review provides a comprehensive examination of the current scientific background supporting the contribution of autoinflammation to HS etiology, including genetic data, molecular studies and clinical evidence, as well as the association between HS and AIDs. However, further research is needed to shed light on the pathogenic mechanism of this challenging condition and to identify potential perspectives for future therapeutic approaches.

摘要

化脓性汗腺炎(HS)是一种慢性且使人衰弱的炎症性皮肤病,其临床表现往往具有异质性,尤其是在罕见的综合征形式中。HS的发病机制源于遗传易感性、先天性和适应性免疫失调、吸烟、肥胖及环境因素的复杂相互作用。在疾病早期,先天性免疫系统过度激活,导致组织损伤并触发适应性免疫反应的激活和放大,而适应性免疫反应在疾病的慢性阶段起关键作用。最近的研究聚焦于阐明先天性免疫损伤和自身炎症在HS中的重要性,并且在著名的单基因和多基因自身炎症综合征(AIDs)背景下该疾病的发生有了越来越多的证据。本综述全面审视了支持自身炎症对HS病因学贡献的当前科学背景,包括遗传数据、分子研究和临床证据,以及HS与AIDs之间的关联。然而,需要进一步研究以阐明这种具有挑战性病症的致病机制,并确定未来治疗方法的潜在前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/501f/11396593/a46c001b3e70/jcm-13-05211-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/501f/11396593/a631dfeefa9f/jcm-13-05211-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/501f/11396593/a46c001b3e70/jcm-13-05211-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/501f/11396593/a631dfeefa9f/jcm-13-05211-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/501f/11396593/a46c001b3e70/jcm-13-05211-g002.jpg

相似文献

1
Evidence on Hidradenitis Suppurativa as an Autoinflammatory Skin Disease.化脓性汗腺炎作为一种自身炎症性皮肤病的证据。
J Clin Med. 2024 Sep 2;13(17):5211. doi: 10.3390/jcm13175211.
2
Case Report: Comorbid Hyper-IgD Syndrome and Hidradenitis Suppurativa - A New Syndromic Form of HS? A Report of Two Cases.病例报告:合并高IgD综合征和化脓性汗腺炎——一种新的化脓性汗腺炎综合征形式?两例报告
Front Immunol. 2022 May 26;13:883811. doi: 10.3389/fimmu.2022.883811. eCollection 2022.
3
Autoinflammation in Syndromic Hidradenitis Suppurativa: The Role of AIM2.综合征性化脓性汗腺炎中的自身炎症:AIM2的作用。
Vaccines (Basel). 2023 Jan 11;11(1):162. doi: 10.3390/vaccines11010162.
4
The genetic aspects of hidradenitis suppurativa.化脓性汗腺炎的遗传学方面。
Clin Dermatol. 2023 Sep-Oct;41(5):551-563. doi: 10.1016/j.clindermatol.2023.08.022. Epub 2023 Aug 29.
5
Hidradenitis Suppurativa as a Potential Subtype of Autoinflammatory Keratinization Disease.化脓性汗腺炎可能是一种炎症性角化病的潜在亚型。
Front Immunol. 2020 May 20;11:847. doi: 10.3389/fimmu.2020.00847. eCollection 2020.
6
PASH, PAPASH, PsAPASH, and PASS: The autoinflammatory syndromes of hidradenitis suppurativa.PASH、PAPASH、PsAPASH 和 PASS:化脓性汗腺炎的自炎症综合征。
Clin Dermatol. 2021 Mar-Apr;39(2):240-247. doi: 10.1016/j.clindermatol.2020.10.016. Epub 2020 Oct 16.
7
Hidradenitis Suppurativa: A Systematic Review Integrating Inflammatory Pathways Into a Cohesive Pathogenic Model.化脓性汗腺炎:将炎症途径整合到一个连贯的致病模型中的系统评价。
Front Immunol. 2018 Dec 14;9:2965. doi: 10.3389/fimmu.2018.02965. eCollection 2018.
8
Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.皮肤科和性病科在莫斯塔尔临床医院用阿达木单抗治疗两例化脓性汗腺炎。
Acta Dermatovenerol Croat. 2021 Jul;29(2):108-110.
9
Hidradenitis Suppurativa-Related Autoinflammatory Syndromes: An Updated Review on the Clinics, Genetics, and Treatment of Pyoderma gangrenosum, Acne and Suppurative Hidradenitis (PASH), Pyogenic Arthritis, Pyoderma gangrenosum, Acne and Suppurative Hidradenitis (PAPASH), Synovitis, Acne, Pustulosis, Hyperostosis and Osteitis (SAPHO), and Rarer Forms.化脓性汗腺炎相关自身炎症性综合征:坏疽性脓皮病、痤疮和化脓性汗腺炎(PASH)、化脓性关节炎、坏疽性脓皮病、痤疮和化脓性汗腺炎(PAPASH)、滑膜炎、痤疮、脓疱病、骨质增生和骨炎(SAPHO)以及更罕见形式的临床、遗传学和治疗的最新综述
Dermatol Clin. 2024 Apr;42(2):247-265. doi: 10.1016/j.det.2023.12.004. Epub 2024 Jan 4.
10
Hidradenitis Suppurativa: An Understanding of Genetic Factors and Treatment.化脓性汗腺炎:对遗传因素及治疗的理解
Biomedicines. 2024 Feb 1;12(2):338. doi: 10.3390/biomedicines12020338.

引用本文的文献

1
Oxidative Stress, High Density Lipoproteins and Hidradenitis Suppurativa: A Prospective Study.氧化应激、高密度脂蛋白与化脓性汗腺炎:一项前瞻性研究。
Antioxidants (Basel). 2025 Aug 19;14(8):1014. doi: 10.3390/antiox14081014.
2
Trained Immunity and Its Potential Implications in the Etiopathogenesis of Hidradenitis Suppurativa: A New Paradigm in Chronic Inflammation?训练有素的免疫及其在化脓性汗腺炎病因发病机制中的潜在影响:慢性炎症的新范式?
Exp Dermatol. 2025 Aug;34(8):e70160. doi: 10.1111/exd.70160.
3
Current Treatments and Future Directions for Hidradenitis Suppurativa: a Narrative Review of Completed and Ongoing Phase 3 Clinical Trials of Biologic Therapies.

本文引用的文献

1
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials.比美吉珠单抗治疗中重度化脓性汗腺炎患者的疗效和安全性(BE HEARD I 和 BE HEARD II):两项为期 48 周、随机、双盲、安慰剂对照、多中心 3 期临床试验。
Lancet. 2024 Jun 8;403(10443):2504-2519. doi: 10.1016/S0140-6736(24)00101-6. Epub 2024 May 22.
2
The coming of age of protein degraders as anti-inflammatory therapeutics.蛋白质降解剂作为抗炎疗法的时代来临。
J Allergy Clin Immunol. 2024 Jul;154(1):76-78. doi: 10.1016/j.jaci.2024.05.006. Epub 2024 May 17.
3
化脓性汗腺炎的当前治疗方法与未来方向:生物疗法已完成及正在进行的3期临床试验的叙述性综述
Dermatol Ther (Heidelb). 2025 Jul 18. doi: 10.1007/s13555-025-01487-y.
4
High-frequency ultrasound in the diagnosis of Hidradenitis suppurativa: experience from the Bulgarian HS Expert Centre.高频超声在化脓性汗腺炎诊断中的应用:来自保加利亚化脓性汗腺炎专家中心的经验
Postepy Dermatol Alergol. 2025 Jun 12;42(3):306-312. doi: 10.5114/ada.2025.151138. eCollection 2025 Jun.
5
Medical Nutrition Therapy in Dermatological Diseases: A Joint Consensus Statement of the Italian Association of Dietetics and Clinical Nutrition (ADI), the Italian Society of Dermatology and Sexually Transmitted Diseases (SIDeMaST), the Italian Society of Nutraceuticals (SINut), Club Ketodiets and Nutraceuticals "KetoNut-SINut" and the Italian Society of Endocrinology (SIE), Club Nutrition, Hormones and Metabolism.皮肤病的医学营养治疗:意大利饮食与临床营养协会(ADI)、意大利皮肤病与性传播疾病学会(SIDeMaST)、意大利营养保健品学会(SINut)、酮饮食与营养保健品俱乐部“KetoNut - SINut”以及意大利内分泌学会(SIE)、营养、激素与代谢俱乐部联合共识声明
Curr Obes Rep. 2025 May 13;14(1):42. doi: 10.1007/s13679-025-00630-2.
6
Endotyping Insulin-Glucose Homeostasis in Hidradenitis Suppurativa: The Impact of Diabetes Mellitus and Inflammation.化脓性汗腺炎中胰岛素-葡萄糖稳态的内型分析:糖尿病和炎症的影响
J Clin Med. 2025 Mar 21;14(7):2145. doi: 10.3390/jcm14072145.
Genetic mutations in pyoderma gangrenosum, hidradenitis suppurativa, and associated autoinflammatory syndromes: Insights into pathogenic mechanisms and shared pathways.
坏疽性脓皮病、化脓性汗腺炎及相关自身炎症综合征中的基因突变:对致病机制和共同途径的见解
J Dermatol. 2024 Sep;51(9):e324-e325. doi: 10.1111/1346-8138.17230. Epub 2024 Apr 11.
4
Proof-of-concept study exploring the effect of spesolimab in patients with moderate-to-severe hidradenitis suppurativa: a randomized double-blind placebo-controlled clinical trial.探索 spesolimab 对中重度化脓性汗腺炎患者影响的概念验证研究:一项随机双盲安慰剂对照临床试验。
Br J Dermatol. 2024 Sep 18;191(4):508-518. doi: 10.1093/bjd/ljae144.
5
The NLRP3 Inflammasome Gene Is Overexpressed in Hidradenitis Suppurativa Lesions: A Preliminary Study on the Role of Pyroptosis in Disease Pathogenesis.NLRP3炎性小体基因在化脓性汗腺炎病变中过表达:细胞焦亡在疾病发病机制中作用的初步研究
Curr Issues Mol Biol. 2024 Mar 16;46(3):2544-2552. doi: 10.3390/cimb46030161.
6
Hidradenitis Suppurativa-Related Autoinflammatory Syndromes: An Updated Review on the Clinics, Genetics, and Treatment of Pyoderma gangrenosum, Acne and Suppurative Hidradenitis (PASH), Pyogenic Arthritis, Pyoderma gangrenosum, Acne and Suppurative Hidradenitis (PAPASH), Synovitis, Acne, Pustulosis, Hyperostosis and Osteitis (SAPHO), and Rarer Forms.化脓性汗腺炎相关自身炎症性综合征:坏疽性脓皮病、痤疮和化脓性汗腺炎(PASH)、化脓性关节炎、坏疽性脓皮病、痤疮和化脓性汗腺炎(PAPASH)、滑膜炎、痤疮、脓疱病、骨质增生和骨炎(SAPHO)以及更罕见形式的临床、遗传学和治疗的最新综述
Dermatol Clin. 2024 Apr;42(2):247-265. doi: 10.1016/j.det.2023.12.004. Epub 2024 Jan 4.
7
Therapeutic Potential of IL-1 Antagonism in Hidradenitis Suppurativa.白细胞介素-1 拮抗剂在化脓性汗腺炎中的治疗潜力。
Biomolecules. 2024 Feb 1;14(2):175. doi: 10.3390/biom14020175.
8
Brepocitinib, Zimlovisertib, and Ropsacitinib in Hidradenitis Suppurativa.布罗莫替尼、齐莫利昔替尼和罗普西替尼治疗化脓性汗腺炎。
NEJM Evid. 2024 Mar;3(3):EVIDoa2300155. doi: 10.1056/EVIDoa2300155. Epub 2024 Feb 9.
9
Emerging Role of the IL-36/IL-36R Axis in Multiple Inflammatory Skin Diseases.IL-36/IL-36R 轴在多种炎症性皮肤疾病中的新作用。
J Invest Dermatol. 2024 Feb;144(2):206-224. doi: 10.1016/j.jid.2023.11.004. Epub 2024 Jan 7.
10
The Pathogenesis and Treatment of Hidradenitis Suppurativa.化脓性汗腺炎的发病机制与治疗
Cureus. 2023 Nov 25;15(11):e49390. doi: 10.7759/cureus.49390. eCollection 2023 Nov.